American heart journal · 2026
Prognostic value of left ventricular contractility index in patients with coarctation of aorta and preserved ejection fraction.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ahmed Marwan, Miranda William R, Ali Ahmed E, Saad Samuel, Connolly Heidi M, Egbe Alexander C
Аннотация
BACKGROUND: Although more than 90% of adults with repaired coarctation of aorta (COA) have preserved left ventricular ejection fraction (LVEF), heart failure (HF) and cardiovascular mortality are relatively common in this population. The purpose of this study was to assess the relationship between LV contractility and clinical outcomes in adults with repaired COA and preserved LVEF.
METHOD: Retrospective cohort study of adults with repaired COA and preserved LVEF (LVEF ≥ 50%) (2003-2024). LV contractility index (LVCi) was assessed as the ratio of brachial systolic blood pressure and LV end-systolic volume index. Based on LVEF and LVCi obtained from the baseline echocardiogram, patients were dichotomized using the median value of LVEF (LVEF_low/normal vs LVEF_high/normal) and LVCi (LVCi_low vs LVCi_high). Study outcomes were peak VO2, NT-proBNP, and all-cause mortality.
RESULTS: Of 821 patients, median LVEF was 63% (56, 70), and median LVCi was 5.8 (4.8, 7.1) mmHg/mL/m2. Compared to LVCi_high group, the LVCi_low group had lower predicted peak VO2, higher NT-proBNP levels and higher incidence of mortality. In contrast, there was no difference in peak VO2, NT-proBNP levels, and mortality between the LVEF_low/normal vs LVEF_high/normal groups. LVCi was independently associated with all-cause mortality and had superior prognostic performance compared to LVEF and LV global longitudinal strain.
CONCLUSIONS: Further studies are required to determine the optimal cutoff point of LVCi that defines reduced LV contractility, and whether patients with reduced LV contractility (in the setting of preserved LVEF) would benefit from medical therapy considering the higher risk of mortality in this subgroup of patients.
METHOD: Retrospective cohort study of adults with repaired COA and preserved LVEF (LVEF ≥ 50%) (2003-2024). LV contractility index (LVCi) was assessed as the ratio of brachial systolic blood pressure and LV end-systolic volume index. Based on LVEF and LVCi obtained from the baseline echocardiogram, patients were dichotomized using the median value of LVEF (LVEF_low/normal vs LVEF_high/normal) and LVCi (LVCi_low vs LVCi_high). Study outcomes were peak VO2, NT-proBNP, and all-cause mortality.
RESULTS: Of 821 patients, median LVEF was 63% (56, 70), and median LVCi was 5.8 (4.8, 7.1) mmHg/mL/m2. Compared to LVCi_high group, the LVCi_low group had lower predicted peak VO2, higher NT-proBNP levels and higher incidence of mortality. In contrast, there was no difference in peak VO2, NT-proBNP levels, and mortality between the LVEF_low/normal vs LVEF_high/normal groups. LVCi was independently associated with all-cause mortality and had superior prognostic performance compared to LVEF and LV global longitudinal strain.
CONCLUSIONS: Further studies are required to determine the optimal cutoff point of LVCi that defines reduced LV contractility, and whether patients with reduced LV contractility (in the setting of preserved LVEF) would benefit from medical therapy considering the higher risk of mortality in this subgroup of patients.